Akira Science on 3D Printing Biomaterials for Tissue Regeneration

As 3D printing continues to revolutionize the healthcare field, more and more companies are exploring its applications in the development of innovative medical solutions. This technology, which excels in customization and precision, is transforming the way devices and materials are designed and produced for the healthcare sector. In the case of tissue engineering and regenerative medicine, 3D printing also offers enormous potential. This is the case of Akira Science, a Swedish company that is already taking advantage of this technology in its activity. Specifically, they have developed 3D printed bioabsorbable polymeric structures to facilitate tissue regeneration in various medical applications. We spoke with the Akira Science team to learn more about this solution and their use of additive manufacturing in medicine.

3DN: Could you introduce yourself and your connection with 3D printing?

My name is Álvaro Morales and I am the CEO of Akira Sciences. My fascination for 3D printing started in 2016, during the Materials Science module during my Chemical Engineering degree, taught by Professor Guillermo Vilariño at UPV. Professor Vilariño’s passion and inspiring methodology in tissue engineering ignited my interest in this technology, which led me to focus my career towards 3D printing and the development of advanced polymeric materials for biomedical applications.

That motivation later led me to pursue my master’s degree at the KTH Royal Institute of Technology in Sweden, I delved into the use of biodegradable polymers through the PrintKnit project, focused on the creation of 3D scaffolds for soft tissue regeneration. This experience not only solidified my vision on the integration of 3D printing into real clinical solutions, but also marked the birth of Akira Science.